Skip to main content
. 2020 Feb 13;9(2):512. doi: 10.3390/jcm9020512

Table 2.

Clinical and biochemical features of the non-obese and obese patients included in this study.

Women Men
Non-obese Obese Non-obese Obese P 2-way-ANOVA
Patients n = 22 n = 44 n = 20 n = 23 Obesity Gender Inter-
Action
Glucose (mg/dL) 94.0 ± 8.7 101.6 ± 2.1 97.8 ± 4.7 98.3 ± 8.7 0.105 0.660 0.836
Insulin (μU/mL) 8.6 ± 1.4 18.2 ± 0.7 5.9 ± 1.7 24.7 ± 5.6 <0.001 0.456 0.063
HbA1C (%) 5.2 ± 0.1 10.6 ± 2.9 5.8 ± 0.7 11.6 ± 4.7 0.053 0.549 0.418
C-Peptide (ng/mL) 2.0± 0.4 4.3 ± 0.2 2.2 ± 0.4 5.8 ± 0.8 <0.001 0.286 0.459
HOMA β (%) 94.2 ± 16.1 134.2 ± 9.1 69.3 ± 10.2 175.4 ± 20.7 <0.001 0.590 0.031
HOMA-S (%) 88.7 ±12.3 41.8 ± 5.3 125.5 ± 11.6 32.4 ± 7.7 <0.001 0.133 0.012
HOMA-IR (AU) 1.1 ± 0.3 2.4 ± 0.2 0.8 ± 0.1 3.1 ± 0.6 <0.001 0.578 0.166
Triglycerides (mg/dL) 77.6 ± 16.8 129.0 ± 34.4 108.8 ± 8.4 163 ± 17.5 0.212 0.449 0.966
Cholesterol (mg/dL) 123.0 ± 13.6 154.7 ± 6.7 162.5 ± 31.0 158.4 ± 11.3 0.601 0.311 0.442
LDL-C (mg/dL) 63.1 ± 8.3 86.0 ± 4.4 94.3 ± 19.6 95 ± 7.6 0.526 0.526 0.54
HDL-C (mg/dL) 44.4 ± 12.8 42.8 ± 2.2 55.7 ± 12.2 34.6 ± 3.7 0.092 0.816 0.147
Leptin (ng/mL) 19.9 ± 8 71.7 ± 7.1 6.8 ± 0.2 28.1 ± 6.8 <0.005 0.062 0.134